Swedencare AB (SWDCF) Q1 2025 Earnings Call Highlights: Navigating Growth and Challenges

Swedencare AB (SWDCF) reports a 7% revenue growth with strategic acquisitions and product expansions, despite a dip in EBITDA.

Author's Avatar
Apr 26, 2025
Summary
  • Revenue: 641 million SEK, 7% growth (5% organic, 2% currency).
  • Gross Margin: Stable at 58.1% compared to 57.9% in the previous period.
  • EBITDA: 124.5 million SEK, a decrease of 10% compared to Q1 last year, with a margin of 19.4%.
  • Interest Expense: Decreased to 12 million SEK from 20 million SEK in Q1 last year.
  • Net Debt to EBITDA Ratio: Reduced to 2.0 from 2.4 a year ago.
  • Operating Cash Flow: 96.7 million SEK, with a cash conversion rate of 78%.
  • CapEx: Less than 2% of sales.
  • North America Revenue: 414 million SEK, 5% growth, representing 65% of total revenue.
  • Europe Revenue Growth: 14%, with strong performance in the UK and Nordics.
  • Dental Product Growth: 51% increase, now 21% of total group revenue.
  • Treat Product Growth: 90% increase, driven by recent acquisitions.
  • Summit Vet Acquisition: Sales of 7.3 million GBP in 2024, EBITDA of 2.7 million GBP, 37% margin.
  • Employee Net Promoter Score (ENPS): Improved from 41 to 44, with a response rate increase from 60% to over 80%.
Article's Main Image

Release Date: April 24, 2025

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

Positive Points

  • Swedencare AB (SWDCF, Financial) reported a solid Q1 with 7% growth, including 5% organic growth.
  • The company successfully launched a new brand design for Nature's Global Pet, with a significant in-store launch planned for Q2.
  • Swedencare AB (SWDCF) improved its employee net promoter score from 41 to 44, with a higher response rate in their biannual employee survey.
  • The acquisition of Summit VET is expected to enhance Swedencare AB (SWDCF)'s presence in the animal health sector, with Summit VET showing strong financial performance.
  • Swedencare AB (SWDCF) achieved a record month in March, with significant growth in their dental product category, which grew by 51%.

Negative Points

  • Swedencare AB (SWDCF) experienced a decrease in EBITDA by 10% compared to Q1 last year, with a margin of 19.4%.
  • Personnel costs increased as a percentage of sales due to cautious sales growth and overtime expenses.
  • The company faced challenges with exclusive agreements with major distributors, impacting growth in certain segments.
  • Swedencare AB (SWDCF) reported a decline in the Innovate brand by 50% compared to Q1 last year due to high orders in the previous year.
  • The company anticipates a potential increase in net debt to EBITDA ratio following the acquisition of Summit VET.

Q & A Highlights

Q: Hakan, you mentioned in the CEO letter that you will achieve double-digit organic growth by the end of 2025. Does that mean for the full year 2025 or just in Q4? How should we interpret the guidance?
A: For the full year 2025.

Q: The EBITDA has been below consensus for four consecutive quarters. Could you help set expectations for operating profit and margins for the year and coming quarters?
A: There have been extraordinary costs and investments, and the organization is now ready for growth. With the expected double-digit growth in the coming quarters, this ratio should improve.

Q: When do you think you will reach the target EBITDA margin of around 25%?
A: I can't specify a quarter, but it should improve quarter after quarter from this quarter. We expect full-year improvement from 2024.

Q: Regarding the acquisition of the Amazon partner for Nature, how will this impact margins, and should we expect an impact in Q2?
A: We are acquiring the stock from our partner, so it won't affect profitability immediately. The project will contribute positively from Q3 onwards, but not significantly impact the margin level.

Q: Could you quantify the sales volume of the 1,400+ Walmart stores in Q2, and elaborate on the magnitude of the launch?
A: I don't have the volume to share, but it will contribute to our double-digit growth in Q2 and beyond. The launch includes 15 to 20 items in an average of 1,100 stores each.

Q: Do you expect double-digit growth in all markets?
A: Yes, in our main geographies, Europe and North America.

Q: How should we consider the margin impact when scaling up the big box business in the second half of the year?
A: It should be neutral to slightly positive in terms of margin impact due to our pricing models.

Q: Should we expect personnel costs and other operational cost ratios to decline in Q2?
A: Yes, I expect them to go down a little in Q2 with increased revenue.

For the complete transcript of the earnings call, please refer to the full earnings call transcript.